Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease. (CROSBI ID 278015)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Švob Štrac, Dubravka ; Konjevod, Marcela, Nikolac Perković, Matea ; Tudor, Lucija ; Nedić Erjavec Gordana ; Pivac, Nela Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease. // Current Alzheimer research, 7 (2020), 141-157. doi: 10.2174/1567205017666200317092310

Podaci o odgovornosti

Švob Štrac, Dubravka ; Konjevod, Marcela, Nikolac Perković, Matea ; Tudor, Lucija ; Nedić Erjavec Gordana ; Pivac, Nela

engleski

Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer's Disease.

BACKGROUND:Neurosteroids dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulphate (DHEAS) are involved in many important brain functions, including neuronal plasticity and survival, cognition and behavior, demonstrating preventive and therapeutic potential in different neuro-psychiatric and neurodegenerative disorders, including Alzheimer's disease. OBJECTIVE: The aim of the article was to provide a comprehensive overview of the literature on the involvement of DHEA and DHEAS in Alzheimer's disease. METHOD: PubMed and MEDLINE databases were searched for relevant literature. The articles were selected considering their titles and abstracts. In the selected full texts, lists of references were searched manually for additional articles. RESULTS: We performed a systematic review of the studies investigating the role of DHEA and DHEAS in various in vitro and animal models, as well as in patients with Alzheimer's disease, and provided a comprehensive discussion on their potential preventive and therapeutic applications. CONCLUSION: Despite mixed results, the findings of various preclinical studies are generally supportive of the involvement of DHEA and DHEAS in the pathophysiology of Alzheimer's disease, showing some promise for potential benefits of these neurosteroids in the prevention and treatment. However, so far small clinical trials brought little evidence to support their therapy in AD. Therefore, large-scale human studies are needed to elucidate the specific effects of DHEA and DHEAS and their mechanisms of action, prior to their applications in clinical practice.

Alzheimer's disease ; Dehydroepiandrosterone ; In vitro studies ; animal models ; dehydroepiandrosterone sulphate ; patients ; treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

7

2020.

141-157

objavljeno

1567-2050

1875-5828

10.2174/1567205017666200317092310

Povezanost rada

Temeljne medicinske znanosti

Poveznice
Indeksiranost